It is known that in breast cancer, a high level of monocytic chemoattractant protein 1 (MCP-1, CCL2) in the tumor tissue and in the circulating blood correlates with an unfavorable prognosis [19,20]. This evidence concerns the gene CCL2 and breast cancer.